The aim of this study was to describe a clinical case of a patient with Alzheimer's disease (AD) in use of an anti-TNF-α agent for rheumatoid arthritis (RA). The patient reported is an 81-year-old Caucasian man and retired teacher, diagnosed with RA in 2008 and AD in 2011. Treatment with donepezil was started in 2011 and the use of etanercept introduced in 2012.
View Article and Find Full Text PDFAm J Alzheimers Dis Other Demen
August 2015
Alzheimer's disease (AD) is the most frequent cause of dementia. This work aims to assess the effectiveness of reality orientation (RO), a traditional, extensively documented cognitive enhancement technique, when combined with acetylcholinesterase inhibitors in the treatment of AD. Fourteen patients with AD having mild to moderate dementia receiving standard treatment with donepezil were randomly assigned to control and treatment groups.
View Article and Find Full Text PDFUnlabelled: Dementia is characterized by deficits in more than one cognitive domain, affecting language, praxis, gnosis, memory or executive functions. Despite the essential economic growth observed in many developing countries, especially over the last century, huge differences remain in health care, whether among nations themselves or across different regions of the same country.
Objective: The aim of this study was to assess the management and main features of dementia, comparing public (PUBL) and private (PRIV) reference services.
The first experimental results obtained from the Canadian SGM beamline at SRC (Synchrotron Radiation Centre, University of Wisconsin-Madison, USA) are reported. The beamline is based on the Dragon-type design, with a constant deviation angle, using photons from a second-generation bending-magnet light source. The medium-energy grating on this beamline covers a photon energy range from 240 to 700 eV, with a ruling density of 600 lines mm(-1).
View Article and Find Full Text PDF